0001567619-21-008236.txt : 20210416 0001567619-21-008236.hdr.sgml : 20210416 20210416171310 ACCESSION NUMBER: 0001567619-21-008236 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210308 FILED AS OF DATE: 20210416 DATE AS OF CHANGE: 20210416 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Yelensky Roman CENTRAL INDEX KEY: 0001754293 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38663 FILM NUMBER: 21832349 MAIL ADDRESS: STREET 1: C/O GRITSTONE ONCOLOGY, INC. STREET 2: 5858 HORTON STREET, SUITE 210 CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gritstone Oncology, Inc. CENTRAL INDEX KEY: 0001656634 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5959 HORTON STREET, SUITE 300 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 871-6100 MAIL ADDRESS: STREET 1: 5959 HORTON STREET, SUITE 300 CITY: EMERYVILLE STATE: CA ZIP: 94608 4 1 doc1.xml FORM 4 X0306 4 2021-03-08 0 0001656634 Gritstone Oncology, Inc. GRTS 0001754293 Yelensky Roman C/O GRITSTONE ONCOLOGY, INC. 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608 0 1 0 0 See Remarks Common Stock 2021-03-08 4 M 0 50724 0.759 A 183948 D Stock Option (Right to Buy) 0.759 2021-03-08 4 M 0 50724 0 D 2027-02-07 Common Stock 50724 0 D Fully exercisable. Executive Vice President and Chief Technology Officer /s/ Rahsaan Thompson, Attorney-in-Fact for Roman Yelensky 2021-04-16